1. Home
  2. CBL vs ORKA Comparison

CBL vs ORKA Comparison

Compare CBL & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBL
  • ORKA
  • Stock Information
  • Founded
  • CBL 1978
  • ORKA 2004
  • Country
  • CBL United States
  • ORKA United States
  • Employees
  • CBL N/A
  • ORKA N/A
  • Industry
  • CBL Real Estate Investment Trusts
  • ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • CBL Real Estate
  • ORKA Health Care
  • Exchange
  • CBL Nasdaq
  • ORKA Nasdaq
  • Market Cap
  • CBL 889.0M
  • ORKA 1.0B
  • IPO Year
  • CBL 1993
  • ORKA N/A
  • Fundamental
  • Price
  • CBL $28.12
  • ORKA $12.25
  • Analyst Decision
  • CBL
  • ORKA Strong Buy
  • Analyst Count
  • CBL 0
  • ORKA 6
  • Target Price
  • CBL N/A
  • ORKA $43.60
  • AVG Volume (30 Days)
  • CBL 209.3K
  • ORKA 413.1K
  • Earning Date
  • CBL 02-10-2025
  • ORKA 02-15-2025
  • Dividend Yield
  • CBL 5.69%
  • ORKA N/A
  • EPS Growth
  • CBL N/A
  • ORKA N/A
  • EPS
  • CBL 1.01
  • ORKA N/A
  • Revenue
  • CBL $523,580,000.00
  • ORKA N/A
  • Revenue This Year
  • CBL N/A
  • ORKA N/A
  • Revenue Next Year
  • CBL N/A
  • ORKA N/A
  • P/E Ratio
  • CBL $27.84
  • ORKA N/A
  • Revenue Growth
  • CBL N/A
  • ORKA N/A
  • 52 Week Low
  • CBL $20.97
  • ORKA $12.24
  • 52 Week High
  • CBL $32.20
  • ORKA $53.88
  • Technical
  • Relative Strength Index (RSI)
  • CBL 34.69
  • ORKA N/A
  • Support Level
  • CBL $28.41
  • ORKA N/A
  • Resistance Level
  • CBL $29.56
  • ORKA N/A
  • Average True Range (ATR)
  • CBL 0.69
  • ORKA 0.00
  • MACD
  • CBL -0.21
  • ORKA 0.00
  • Stochastic Oscillator
  • CBL 0.75
  • ORKA 0.00

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a U.S.-based real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

About ORKA Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.

Share on Social Networks: